Direct oral Anticoagulants versus warfarin for stroke prevention in atrial fibrillation: a subgroup meta-analysis in European patients

Direct oral Anticoagulants versus warfarin for stroke prevention in atrial fibrillation: a subgroup meta-analysis in European patients

Material and methods We searched MEDLINE and CENTRAL (up to February 2015), regulatory agencies websites, clinical trials registers, and conference proceedings to identify randomized controlled trials of the direct oral anticoagulants (DOAC; dabigatran, rivaroxaban, apixaban, edoxaban) versus warfar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2015-08, Vol.37 (8), p.e10-e10
Hauptverfasser: Gómez-Outes, A, Suárez-Gea, M.L, Terleira-Fernández, A.I, Vargas-Castrillón, E, Calvo-Rojas, G
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Confidence intervals
Internal Medicine
Medical Education
Stroke
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Material and methods We searched MEDLINE and CENTRAL (up to February 2015), regulatory agencies websites, clinical trials registers, and conference proceedings to identify randomized controlled trials of the direct oral anticoagulants (DOAC; dabigatran, rivaroxaban, apixaban, edoxaban) versus warfarin for prevention of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (NVAF).
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2015.05.039